EXPO

Exponent, Inc. [EXPO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

EXPO Stock Summary

Top EXPO Correlated Resources

EXPO


Top 10 Correlated ETFs

EXPO


Top 10 Correlated Stocks

EXPO


In the News

12:00 05 Dec 2022 EXPO

Exponent: Entering Back Into Buy Range, If Sentiment Holds

Exponent is a leading consulting firm, an area of the market with stable and quality performance assets. Unfortunately, EXPO's valuation got ahead of itself and I sold in late 2021.

06:48 05 Dec 2022 EXPO

Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates

Exponent (EXPO) delivered earnings and revenue surprises of 11.90% and 1%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

05:33 05 Dec 2022 EXPO

Exponent, Inc. (EXPO) Q3 2022 Earnings Call Transcript

Exponent, Inc. (NASDAQ:EXPO ) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations Catherine Ford Corrigan - President and Chief Executive Officer Richard Schlenker - Executive Vice President, Chief Financial Officer & Corporate Secretary Conference Call Participants Operator Good day and welcome to the Exponent, Incoporated Third Quarter of Fiscal Year 2022 Financial Results Conference Call. Today's conference is being recorded.

04:05 05 Dec 2022 EXPO

Exponent to Announce Third Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on October 27, 2022

MENLO PARK, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report third quarter of fiscal year 2022 financial results for the period ended September 30, 2022 following the close of the market on Thursday, October 27, 2022. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.

10:57 05 Dec 2022 EXPO

The 5 Smartest Investments In The Market

Retail investors are often at a disadvantage, but one simple way to win is by investing in the "smartest" companies. This article will present five companies that I believe are the smartest and explain why.

12:30 05 Dec 2022 EXPO

India's Exponent Energy may have found the secret to 15 min rapid EV charging

Bangalore-based Exponent Energy might have come up with a way to deliver 15-minute rapid charging for electric vehicles. The startup, which just raised a $13 million Series A, relies on a combination of its proprietary battery pack and charging infrastructure to achieve such a feat.

10:30 05 Dec 2022 EXPO

Exponent, Inc. (EXPO) CEO Catherine Ford Corrigan on Q2 2022 Results - Earnings Call Transcript

Exponent, Inc. (NASDAQ:EXPO ) Q2 2022 Results Earnings Conference Call July 28, 2022 4:30 PM ET Company Participants Joni Konstantelos - Investor Relations, Clermont Partners Catherine Ford Corrigan - President and Chief Executive Officer Richard Schlenker - Executive Vice President, Chief Financial Officer and Corporate Secretary Conference Call Participants Tobey Sommer - Truist Securities Operator Good day and welcome to the Exponent, Inc. Second Quarter of Fiscal Year 2022 Financial Results Conference Call. Today's conference is being recorded.

06:44 05 Dec 2022 EXPO

Exponent (EXPO) Q2 Earnings Surpass Estimates

Exponent (EXPO) delivered earnings and revenue surprises of 8.89% and 0.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

04:05 05 Dec 2022 EXPO

Exponent to Announce Second Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on July 28, 2022

MENLO PARK, Calif., July 07, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report second quarter of fiscal year 2022 financial results for the period ended July 1, 2022 following the close of the market on Thursday, July 28, 2022. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results.

02:00 05 Dec 2022 EXPO

Exponent to Present at Upcoming Investor Conferences

MENLO PARK, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the following investor conferences:

EXPO Financial details

Company Rating
Strong Buy
Market Cap
5.25B
Income
100.19M
Revenue
499.44M
Book val./share
6.21
Cash/share
2.88
Dividend
0.72
Dividend %
0.69%
Employees
958
Optionable
No
Shortable
Yes
Earnings
01 Feb 2023
P/E
54.89
Forward P/E
74.63
PEG
23.79
P/S
10.7
P/B
16.7
P/C
36.02
P/FCF
55.11
Quick Ratio
2.28
Current Ratio
2.41
Debt / Equity
0.04
LT Debt / Equity
0.04
-
-
EPS (TTM)
1.92
EPS next Y
1.39
EPS next Q
0.35
EPS this Y
23.83%
EPS next Y
-27.86%
EPS next 5Y
-27.86%
EPS last 5Y
16.63%
Revenue last 5Y
8.15%
Revenue Q/Q
-2.38%
EPS Q/Q
-6%
-
-
-
-
SMA20
8.13%
SMA50
12.41%
SMA100
11.12%
Inst Own
83.37%
Inst Trans
-2.15%
ROA
18%
ROE
27%
ROC
0.34%
Gross Margin
26%
Oper. Margin
28%
Profit Margin
20%
Payout
37%
Shs Outstand
51.12M
Shs Float
50.8M
-
-
-
-
Target Price
-
52W Range
80.97-126.31
52W High
-17.67%
52W Low
+29.68%
RSI
63.7
Rel Volume
0.73
Avg Volume
180.33K
Volume
131.51K
Perf Week
3.04%
Perf Month
17.78%
Perf Quarter
24.51%
Perf Half Y
14.5%
-
-
-
-
Beta
0.619151
-
-
Volatility
1.24%, 4.27%
Prev Close
0.79%
Price
103.74
Change
-0.58%

EXPO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2016-12-302017-12-292018-12-282020-01-03 2021-12-31
Revenue per share
5.956.67.177.928.86
Net income per share
0.90.781.371.561.92
Operating cash flow per share
1.261.291.722.052.37
Free cash flow per share
0.991.21.421.612.24
Cash per share
3.283.733.944.45.65
Book value per share
5.165.485.936.657.92
Tangible book value per share
55.325.776.487.76
Share holders equity per share
5.165.485.936.657.92
Interest debt per share
0000.110.28
Market cap
1.53B2.04B2.67B3.83B4.93B
Enterprise value
1.41B1.92B2.54B3.66B4.64B
P/E ratio
32.1949.436.9146.548.69
Price to sales ratio
4.855.877.039.1910.57
POCF ratio
22.8330.0829.2535.4839.55
PFCF ratio
29.0832.3335.6145.141.85
P/B Ratio
5.597.068.510.9511.81
PTB ratio
5.597.068.510.9511.81
EV to sales
4.495.516.698.789.96
Enterprise value over EBITDA
18.7821.5725.533.0135.1
EV to operating cash flow
21.1128.2427.8533.9137.28
EV to free cash flow
26.8930.3533.9243.0939.45
Earnings yield
0.030.020.030.020.02
Free cash flow yield
0.030.030.030.020.02
Debt to equity
00000.02
Debt to assets
0.320.340.330.380.39
Net debt to EBITDA
-1.53-1.41-1.28-1.54-2.14
Current ratio
3.423.393.322.942.96
Interest coverage
00000
Income quality
1.411.641.261.311.23
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.40.530.380.410.43
Sales general and administrative to revenue
0.660.660.610.680.63
Research and developement to revenue
00000
Intangibles to total assets
0.020.020.020.020.01
Capex to operating cash flow
-0.21-0.07-0.18-0.21-0.05
Capex to revenue
-0.05-0.01-0.04-0.06-0.01
Capex to depreciation
-2.35-0.75-2.59-3.38-1.05
Stock based compensation to revenue
0.040.050.040.040.04
Graham number
10.29.8313.515.318.51
ROIC
0.190.210.250.190.21
Return on tangible assets
0.120.10.160.150.15
Graham Net
2.062.442.512.062.58
Working capital
193.81M222.4M228.31M240.08M299.78M
Tangible asset value
264.74M280.48M305.3M341.64M408.46M
Net current asset value
143.65M165.01M171.59M150.88M186.09M
Invested capital
0000.020.04
Average receivables
113.64M124.98M122.84M130M139.86M
Average payables
00000
Average inventory
00000
Days sales outstanding
101.26115.55101.76105.11109.48
Days payables outstanding
73.456.0337.4265.680
Days of inventory on hand
00000
Receivables turnover
3.63.163.593.473.33
Payables turnover
4.976.519.755.560
Inventory turnover
00000
ROE
0.170.140.230.240.24
Capex per share
-0.27-0.09-0.31-0.44-0.13

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-10-012021-12-312022-04-012022-07-01 2022-09-30
Revenue per share
2.212.162.452.512.47
Net income per share
0.470.390.560.50.47
Operating cash flow per share
0.471.03-0.120.580.57
Free cash flow per share
0.451-0.170.520.51
Cash per share
4.845.654.13.192.88
Book value per share
7.77.927.376.56.21
Tangible book value per share
7.537.767.216.346.04
Share holders equity per share
7.77.927.376.56.21
Interest debt per share
0.310.280.320.320.37
Market cap
6.03B6.15B5.68B4.75B4.51B
Enterprise value
5.81B5.86B5.48B4.6B4.38B
P/E ratio
61.3275.3947.9546.1346.17
Price to sales ratio
51.7854.1444.236.4835.5
POCF ratio
241.83113.41-894.06157.54153.44
PFCF ratio
253.97116.39-633.97176.94172.12
P/B Ratio
14.8814.7414.6914.0814.12
PTB ratio
14.8814.7414.6914.0814.12
EV to sales
49.9551.6542.6635.3434.47
Enterprise value over EBITDA
170.84194.14158.79123.03113.77
EV to operating cash flow
233.27108.19-862.88152.6149.02
EV to free cash flow
244.97111.04-611.85171.39167.17
Earnings yield
000.010.010.01
Free cash flow yield
00.0100.010.01
Debt to equity
0.030.020.030.030.04
Debt to assets
0.370.390.370.40.43
Net debt to EBITDA
-6.27-9.36-5.74-3.98-3.37
Current ratio
3.32.963.452.692.41
Interest coverage
001.75K258.7357.7
Income quality
1.012.66-0.211.171.2
Dividend Yield
00000
Payout ratio
0.420.510.420.480.5
Sales general and administrative to revenue
0.590.640.570.490.55
Research and developement to revenue
00000
Intangibles to total assets
0.010.010.010.020.02
Capex to operating cash flow
-0.05-0.030.41-0.11-0.11
Capex to revenue
-0.01-0.01-0.02-0.03-0.03
Capex to depreciation
-0.72-0.9-1.54-1.83-1.85
Stock based compensation to revenue
0.040.040.050.040.04
Graham number
8.998.319.688.528.14
ROIC
0.060.040.070.10.09
Return on tangible assets
0.040.030.050.050.04
Graham Net
2.462.581.811.110.66
Working capital
291.14M299.78M267.58M215M194.6M
Tangible asset value
396.38M408.46M377.96M328.89M311.19M
Net current asset value
184.24M186.09M145.71M113.32M93.31M
Invested capital
0.040.040.040.050.06
Average receivables
152.91M150.82M154.64M161.77M163.89M
Average payables
24.06M14.93M28.75M26.67M29.25M
Average inventory
00000
Days sales outstanding
111.37110.9103.33111.76117.48
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
0.810.810.870.810.77
Payables turnover
00000
Inventory turnover
00000
ROE
0.060.050.080.080.08
Capex per share
-0.02-0.03-0.05-0.06-0.06

EXPO Frequently Asked Questions

What is Exponent, Inc. stock symbol ?

Exponent, Inc. is a US stock , located in Menlo park of California and trading under the symbol EXPO

What is Exponent, Inc. stock quote today ?

Exponent, Inc. stock price is $103.74 today.

Is Exponent, Inc. stock public?

Yes, Exponent, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks